EziSurg Medical Secures GPO Contract with Vizient

Frisco,Texas, March 31, 2025 — EziSurg Medical Co., Ltd., a leading innovator in minimally invasive surgical solutions (MIS), proudly announces that its U.S. subsidiary, ESM Trading LLC, has secured a supplier agreement for endo-mechanic catalog with Vizient, Inc., the largest Group Purchasing Organizations (GPOs) in the United States. This achievement officially designates EziSurg Medical as a Vizient-approved supplier, marking a significant step into the mainstream U.S. medical device market.

GPOs play a pivotal role of the U.S. healthcare system, streamlining the procurement of medical supplies and devices for hospitals, clinics, and ambulatory surgical centers (ASCs). As a leading GPO in the U.S., Vizient represents a contract portfolio with an annual purchasing volume over USD 130 billion, serves more than 50% of the nation's acute care providers.

The United States stands as the largest single market for medical devices, accounting for roughly 40% of global sales[1], with a steadily growing demand for innovative MIS solutions. According to Global Market Insights, the U.S. surgical staplers market was valued at USD 2.1 billion in 2023 and is projected to reach USD 3.7 billion by 2032, growing at a CAGR of 6.7% from 2024 to 2032[2].

Through its successful contract with Vizient, EziSurg Medical is poised to expand its reach across a vast network of U.S. healthcare providers. With a strong commitment to innovation and quality, EziSurg Medical has successfully met the stringent regulatory and market entry requirements in the U.S., its core surgical stapler product line, including the easyEndo™ Universal Staplers, easyLC™ Linear Cutting Staplers, easyEndo™ Lite Linear Cutting Staplers, and easyCS™ Circular Staplers has received FDA clearance and achieved full acceptance in this GPO contract.

Mr. Henry Nie

Founder and Chairman of EziSurg Medical

We are honored to announce our contract with Vizient, a leading GPO in the U.S. This pivotal milestone underscores EziSurg Medical's commitment to excellence in R&D, manufacturing, and commercialization, enabling us to provide Vizient members advanced and competitive MIS solutions. The U.S. has always been a key strategic market—professional, mature, and vast in scale. Winning this contract is a pivotal step in our global strategy, and we look forward to collaborating with local partners to drive new opportunities. Going forward, we will further streamline our supply chain, strengthen delivery reliability for the U.S. market, and provide high-quality products and services that create real value for U.S. healthcare providers and patients.

References

[1] MedPac (2017) An overview of the medical device industry. Available at: https://www.medpac.gov/wp-content/uploads/import_data/scrape_files/docs/default-source/reports/jun17_ch7.pdf.

[2] Wani, G. and Faizullabhoy, M. (2024) U.S. Surgical Staplers Market - By Product (Linear, Circular, Skin, Endoscopic), Technology (Manual, Powered), Usability (Reusable, Disposable), Surgery (Gynaecology, Cardiac, Bariatric, Colorectal), End-use (Hospitals, ASCs), & Forecast, 2024–2032, Global Market Insights Inc. Available at: https://www.gminsights.com/industry-analysis/us-surgical-staplers-market.

About Ezisurg Medical

EziSurg Medical Co., Ltd. (referred to as“EziSurg Medical”) was established in November 2011 in Shanghai, specializes in the R&D and industrialization of premium minimally invasive surgery (MIS) solutions worldwide. 

With a highly competitive product portfolio including surgical stapling series, surgical energy platform and surgical endoscopy platform, EziSurg is committed to improving surgical outcomes in general, bariatric, thoracic and colorectal procedures, to become a preferred global provider of reliable, accessible, and affordable comprehensive MIS solutions. To date, EziSurg Medical's self-developed products have achieved cumulative global sales of nearly 5 millionunits and have been used in over 1,400 hospitals across China, of which Grade A tertiary hospitals account for more than 40%. In the international front, EziSurg Medical has received entry approvals of more than 80 countries and regions worldwide.

For more information, please visit: https://en.ezisurg.com